[Experience with the use of ketamine in psychiatric practice].
Twenty-nine schizophrenic patients showing therapeutic resistance to the conventional methods of treatment with psychotropic agents were subjected to the therapy with ketamine, a drug used as an anesthetic in surgery. The choice of the drug for treating mentally ill patients was determined by its capacity to bring about therapeutically expedient transient manifestations of drug-induced psychosis, therapy activating the central nervous system. Schizophrenics exhibiting manifestations of depressive inhibition and apathoabulic states benefited from ketamine treatment. The proposed method is technically simple and free of any side effects or complications.
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007649:Ketamine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013610:Tachycardia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D014150:Antipsychotic Agents; D007649:Ketamine
Opyt primeneniia ketamina v psikhiatricheskoĭ praktike.